Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) characterized by acute pneumonia which may progress to respiratory failure and life-threatening complications, including acute respiratory distress syndrome (ARDS) and multisystem or...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Dreden, Patrick, Voiriot, Guillaume, Alabbadi, Alexandre, Elalamy, Ismail, Papageorgiou, Loula, Cost, Hélène, Rousseau, Aurélie, Turpin, Matthieu, Fartoukh, Muriel, Gerotziafas, Grigorios T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
331.Pathophysiology of Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330376/
http://dx.doi.org/10.1182/blood-2020-140275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330376/
http://dx.doi.org/10.1182/blood-2020-140275

Ejemplares similares